Centene Corporation

Centene Corporation

CNCNYSE / NASDAQHealthcareLarge cap

$63.78-$1.80 (-2.7%)

Last close · Data as of Nov 20, 2026

Market cap
$31.0B
P/E
-4.6x
EV / EBITDA
-6.5x
Revenue
$194.8B
Net margin
-3.4%
ROCE
-0.8%

+83.1% over the last year

Centene Corporation price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-9.9%
3M
-0.6%
6M
+9.4%
1Y
+83.1%
5Y
-12.6%

52-week range

Day change -$1.80 (-2.7%) from $66 to $64 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in CNC, bought on each weekday since 2021.

News & filings

What Centene filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernThe company made a net loss of 6.7 billion US dollars in fiscal 2025.

Strengths (1)

  • Free cash flow in fiscal 2025 equals 14.0% of the company's market value.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other.

Read moreShow less

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Sector
Healthcare
Shares outstanding
491.8M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$31.0B
P/E
-4.6x
P/B
1.6x
EV / EBITDA
-6.5x
EV / Sales
0.2x
P/S
0.2x
52-week high
$76.01
52-week low
$31.80

Profitability

Operating margin
-0.2%
Net margin
-3.4%
EBITDA margin
-2.5%
ROE
-33.4%
ROCE
-0.8%
ROA
-8.7%
Asset turnover
2.54

Growth

Revenue
$194.8B
Revenue growth, 1Y
19.4%
Revenue CAGR, 3Y
10.5%
Net profit growth, 1Y
-301.9%
Free cash flow
$4.3B

Solvency

Current ratio
1.10
Debt / Equity
0.91
Debt / Assets
0.24
CFO / Net profit
-0.76
Cash / Market cap
57.8%

Where the revenue went

FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.

LineFY2025
Revenue$194.8B
Cost of revenue$180.9B
Gross profit$13.9B
Operating expenses$14.2B
Selling, general and administrative$12.9B
Operating income-$312.0M
Interest and other-$6.4B
Pretax income-$6.7B
Tax and other-$54.0M
Net income-$6.7B

Revenue and net profit

Revenue grew 19.4% in FY2025; net profit is the dashed line.

Centene Corporation revenue and net profit by fiscal year
Centene Corporation revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$144.5B$1.2B
FY2023$154.0B$2.7B
FY2024$163.1B$3.3B
FY2025$194.8B-$6.7B

Cash flows

FY2025: $5.1B from operations, $4.3B free after investment (dashed).

Centene Corporation operating and free cash flow by fiscal year
Centene Corporation operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$6.3B$5.3B
FY2023$8.1B$7.3B
FY2024$154.0M-$490.0M
FY2025$5.1B$4.3B

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$194.8B+19.4%1Y
EBITDA
-$4.8B-177.0%1Y
Net profit
-$6.7B-301.9%1Y
Cash from operations
$5.1B+3,203.9%1Y
Free cash flow
$4.3B
Revenue CAGR, 3Y
10.5%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$194.8B-$4.8B-$6.7B$4.3B-33.4%+19.4%-301.9%

Monthly returns

Month-by-month returns of CNC across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$76.7B
Liabilities$56.7B
Equity$20.1B
Paid-in capital$20.8B
Retained earnings$8.7B
Treasury stock$9.4B
Minority interest$103.0M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; CNC highlighted.

P/E against peers

CNC has no positive P/E; the peer median is 22.7x.

Not shown (no positive earnings and no EV / Sales): Centene Corporation.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Centene CorporationCNCthis company$31.0B-4.6x1.6x-33.4%-6.5x
Waters CorporationWAT$37.0B57.5x14.4x25.1%36.7x
Zoetis Inc.ZTS$33.3B12.5x10.0x80.2%9.9x
IQVIA Holdings Inc.IQV$31.2B22.9x4.8x20.9%13.0x
GE HealthCare Technologies Inc.GEHC$29.0B13.9x2.8x20.1%9.2x
Biogen Inc.BIIB$29.0B22.4x1.6x7.1%12.5x
ResMed Inc.RMD$28.2B20.1x4.7x23.5%14.5x
DexCom, Inc.DXCM$28.0B33.5x10.2x30.5%21.0x
Mettler-Toledo International Inc.MTD$23.9B27.4x—-3676.8%20.9x
Peer median—22.7x4.8x22.2%13.8x

Year-to-date ROI

CNC since 1 January, against earlier years.

Historical volatility

CNC's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Centene Corporation operating margin by fiscal year
Centene Corporation operating margin by fiscal year
DateOperating margin
FY20222.5%
FY20232.2%
FY20242.0%
FY2025-0.2%
LineFY2025
Cost of revenueCost Of Revenue$180.9B
Gross profitGross Profit$13.9B
Operating expensesOperating Expense$14.2B
Depreciation and amortisationDepreciation And Amortization In Income Statement$1.3B
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$1.3B
Depreciation income statementDepreciation Income Statement$590.0M
Amortization$685.0M
Amortisation of intangiblesAmortization Of Intangibles Income Statement$685.0M
Insurance and claimsInsurance And Claims—
Total expensesTotal Expenses$195.1B
Pretax incomePretax Income-$6.7B

Learn while you research

Academy chapters picked for Centene Corporation and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  3. 03 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  4. 04 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →